Recipient-Derived Cells after Cord Blood Transplantation: Dynamics Elucidated by Multicolor FACS, Reflecting Graft Failure and Relapse

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 6, 2008, Pages 693-701

  Watanabe, Nobukazu ^a   Takahashi, Satoshi ^b   Ishige, Masayuki ^a   Ishii, Yumiko ^a   Ooi, Jun ^b   Tomonari, Akira ^b   Tsukada, Nobuhiro ^b   Konuma, Takaaki ^b   Kato, Seiko ^b   Sato, Aki ^b   Tojo, Arinobu ^b   Nakauchi, Hiromitsu ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Chimerism; Cord blood transportation; Flow cytometry; HLA

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DNA; FLUDARABINE; HLA ANTIBODY; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; B LYMPHOCYTE; CANCER RELAPSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CHIMERA; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; EARLY DIAGNOSIS; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; GRANULOCYTE; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HUMAN; HUMAN CELL; MINIMAL RESIDUAL DISEASE; MONOCYTE; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; NONMYELOABLATIVE CONDITIONING; PHENOTYPIC VARIATION; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS;

ADULT; ANTIBODIES, MONOCLONAL; BLOOD CELL COUNT; CELL DIFFERENTIATION; CELL LINEAGE; CELL SEPARATION; CORD BLOOD STEM CELL TRANSPLANTATION; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; LEUKEMIA; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MONOCYTES; NEOPLASTIC STEM CELLS; PHENOTYPE; RECURRENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 43449087008     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.04.001     Document Type: Article

References (26)

1. Thiede C., Florek M., Bornhauser M., et al. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant 23 (1999) 1055-1060
2. Turkiewicz D., Gorczynska E., Toporski J., et al. Monitoring of hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation (alloSCT) by dual-color FISH analysis of X and Y chromosomes. Leuk Res 27 (2003) 993-998
3. Gardiner N., Lawler M., O'Riordan J., De'Arce M., and McCann S.R. Donor chimaerism is a strong indicator of disease free survival following bone marrow transplantation for chronic myeloid leukaemia. Leukemia 11 Suppl 3 (1997) 512-515
4. Bader P., Beck J., Frey A., et al. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant 21 (1998) 487-495
5. Serrano J., Roman J., Sanchez J., et al. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse. Blood 95 (2000) 2659-2665
6. Bader P., Kreyenberg H., Hoelle W., et al. Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective. Bone Marrow Transplant 33 (2004) 815-821
7. Bader P., Niethammer D., Willasch A., Kreyenberg H., and Klingebiel T. How and when should we monitor chimerism after allogeneic stem cell transplantation?. Bone Marrow Transplant 35 (2005) 107-119
8. Beck O., Seidl C., Lehrnbecher T., et al. Quantification of chimerism within peripheral blood, bone marrow and purified leukocyte subsets: comparison of singleplex and multiplex PCR amplification of short tandem repeat (STR) loci. Eur J Haematol 76 (2006) 237-244
9. Miura Y., Tanaka J., Toubai T., et al. Analysis of donor-type chimerism in lineage-specific cell populations after allogeneic myeloablative and non-myeloablative stem cell transplantation. Bone Marrow Transplant 37 (2006) 837-843
10. De Rosa S.C., Brenchley J.M., and Roederer M. Beyond six colors: a new era in flow cytometry. Nat Med 9 (2003) 112-117
11. Chattopadhyay P.K., Price D.A., Harper T.F., et al. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nat Med 12 (2006) 972-977
12. Petrovas C., Casazza J.P., Brenchley J.M., et al. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med 203 (2006) 2281-2292
13. Precopio M.L., Betts M.R., Parrino J., et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J Exp Med 204 (2007) 1405-1416
14. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351 (2004) 2265-2275
15. Rocha V., Labopin M., Sanz G., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351 (2004) 2276-2285
16. Takahashi S., Ooi J., Tomonari A., et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 109 (2007) 1322-1330
17. Terasaki P.I., and McClelland J.D. Microdroplet assay of human serum cytotoxins. Nature 204 (1964) 998-1000
18. Sijpkens Y.W., Doxiadis II, De Fijter J.W., et al. Sharing cross-reactive groups of MHC class I improves long-term graft survival. Kidney Int 56 (1999) 1920-1927
19. Pei R., Chen T., Orpilla J., and Lee J.H. A simultaneous negative and positive selection method that can detect chimerism at a frequency of 1 per 10,000 by flow cytometry. Tissue Antigens 50 (1997) 197-201
20. Metes D., Logar A., Rudert W.A., et al. Four-color flow cytometric analysis of peripheral blood donor cell chimerism. Hum Immunol 64 (2003) 787-795
21. Gratama J.W., Orfao A., Barnett D., et al. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry 34 (1998) 128-142
22. Lacombe F., Durrieu F., Briais A., et al. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia 11 (1997) 1878-1886
23. Kern W., Voskova D., Schnittger S., Schoch C., Hiddemann W., and Haferlach T. Four-fold staining including CD45 gating improves the sensitivity of multiparameter flow cytometric assessment of minimal residual disease in patients with acute myeloid leukemia. Hematol J 5 (2004) 410-418
24. Dobo I., Pineau D., Robillard N., et al. Standardization of the CFU-GM assay: advantages of plating a fixed number of CD34+ cells in collagen gels. J Hematother Stem Cell Res 12 (2003) 543-551
25. Mageed A.S., Pietryga D.W., DeHeer D.H., and West R.A. Isolation of large numbers of mesenchymal stem cells from the washings of bone marrow collection bags: characterization of fresh mesenchymal stem cells. Transplantation 83 (2007) 1019-1026
26. Schumm M., Feuchtinger T., Pfeiffer M., et al. Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation. Bone Marrow Transplant 39 (2007) 767-773